Lung Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 18 years or older
- People who have been diagnosed with early-stage non-small cell lung cancer (a common type of lung cancer) and have had surgery to fully remove the tumour
- People for whom enough tumour tissue and blood samples are available for the study to use
- People whose medical records, scan results, and follow-up appointment information are available for the study
- People who have given written agreement to take part in the study
Who may not be able to join:
- People who have had another type of cancer in the past
- People who had signs of cancer spreading to other parts of the body before their surgery
- People for whom there is not enough tumour tissue or blood sample available for the study to use
- People whose medical records, scan results, or follow-up information are not available
- People who the study doctor determines should not take part, for any other reason
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Jun Wang, Peking University People's Hospital
Phone: +86-010-88326657
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Disease-free survival (DFS); Overall survival (OS)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.